• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大安大略省肾脏项目之间肾移植机会的差异。

Variation in Access to Kidney Transplantation Across Renal Programs in Ontario, Canada.

机构信息

Institute for Clinical Evaluative Sciences (ICES), London, Ontario, Canada.

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

出版信息

Am J Transplant. 2017 Jun;17(6):1585-1593. doi: 10.1111/ajt.14133. Epub 2017 Jan 9.

DOI:10.1111/ajt.14133
PMID:28068455
Abstract

In the United States, kidney transplant rates vary significantly across end-stage renal disease (ESRD) networks. We conducted a population-based cohort study to determine whether there was variability in kidney transplant rates across renal programs in a health care system distinct from the United States. We included incident chronic dialysis patients in Ontario, Canada, from 2003 to 2013 and determined the 1-, 5-, and 10-year cumulative incidence of kidney transplantation in 27 regional renal programs (similar to U.S. ESRD networks). We also assessed the cumulative incidence of kidney transplant for "healthy" dialysis patients (aged 18-50 years without diabetes, coronary disease, or malignancy). We calculated standardized transplant ratios (STRs) using a Cox proportional hazards model, adjusting for patient characteristics (maximum possible follow-up of 11 years). Among 23 022 chronic dialysis patients, the 10-year cumulative incidence of kidney transplantation ranged from 7.4% (95% confidence interval [CI] 4.8-10.7%) to 31.4% (95% CI 16.5-47.5%) across renal programs. Similar variability was observed in our healthy cohort. STRs ranged from 0.3 (95% CI 0.2-0.5) to 1.5 (95% CI 1.4-1.7) across renal programs. There was significant variation in kidney transplant rates across Ontario renal programs despite patients having access to the same publicly funded health care system.

摘要

在美国,终末期肾病(ESRD)网络中的肾脏移植率存在显著差异。我们进行了一项基于人群的队列研究,以确定在一个与美国不同的医疗保健系统中,肾脏计划之间的肾脏移植率是否存在差异。我们纳入了 2003 年至 2013 年加拿大安大略省的新发慢性透析患者,并确定了 27 个区域肾脏计划(类似于美国 ESRD 网络)中 1、5 和 10 年的累积肾脏移植发生率。我们还评估了“健康”透析患者(年龄在 18-50 岁,无糖尿病、冠心病或恶性肿瘤)的肾脏移植累积发生率。我们使用 Cox 比例风险模型计算了标准化移植比(STR),并根据患者特征进行了调整(最大随访时间为 11 年)。在 23022 名慢性透析患者中,肾脏计划之间的 10 年累积肾脏移植发生率从 7.4%(95%置信区间 4.8-10.7%)到 31.4%(95%置信区间 16.5-47.5%)不等。在我们的健康队列中也观察到了类似的变异性。STR 从肾脏计划的 0.3(95%置信区间 0.2-0.5)到 1.5(95%置信区间 1.4-1.7)不等。尽管患者可以获得相同的公共资助医疗保健系统,但安大略省肾脏计划之间的肾脏移植率存在显著差异。

相似文献

1
Variation in Access to Kidney Transplantation Across Renal Programs in Ontario, Canada.加拿大安大略省肾脏项目之间肾移植机会的差异。
Am J Transplant. 2017 Jun;17(6):1585-1593. doi: 10.1111/ajt.14133. Epub 2017 Jan 9.
2
Variation in Kidney Transplant Referral Across Chronic Kidney Disease Programs in Ontario, Canada.加拿大安大略省慢性肾病项目中肾移植转诊的差异。
Can J Kidney Health Dis. 2023 Jun 14;10:20543581231169608. doi: 10.1177/20543581231169608. eCollection 2023.
3
Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada.加拿大安大略省透析患者与尸体供肾首次肾移植受者死亡风险的比较。
J Am Soc Nephrol. 2000 May;11(5):917-922. doi: 10.1681/ASN.V115917.
4
Standardized Transplantation Referral Ratio to Assess Performance of Transplant Referral among Dialysis Facilities.标准化移植推荐比评估透析机构移植推荐的表现。
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):282-289. doi: 10.2215/CJN.04690417. Epub 2018 Jan 25.
5
Duration of end-stage renal disease and kidney transplant outcome.终末期肾病的病程与肾移植结果。
Nephrol Dial Transplant. 2005 Jan;20(1):167-75. doi: 10.1093/ndt/gfh541. Epub 2004 Nov 16.
6
Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes.美国非优先活体供肾移植前透析暴露的差异及其与移植物结局的关系。
Am J Kidney Dis. 2018 May;71(5):636-647. doi: 10.1053/j.ajkd.2017.11.012. Epub 2018 Feb 1.
7
Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities.与美国透析机构中低肾移植率相关的透析机构和网络因素。
Am J Transplant. 2014 Jul;14(7):1562-72. doi: 10.1111/ajt.12749. Epub 2014 May 29.
8
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
9
Hemodialysis Arteriovenous Vascular Access Creation After Kidney Transplant Failure.移植肾失败后行血液透析动静脉血管通路的建立。
Am J Kidney Dis. 2015 Oct;66(4):646-54. doi: 10.1053/j.ajkd.2015.03.031. Epub 2015 May 12.
10
Impact of Socioeconomic Status on Incidence of End-Stage Renal Disease and Mortality After Dialysis in Adults With Diabetes.社会经济地位对糖尿病患者透析后终末期肾病发生率和死亡率的影响。
Can J Diabetes. 2019 Oct;43(7):483-489.e4. doi: 10.1016/j.jcjd.2019.04.006. Epub 2019 Apr 17.

引用本文的文献

1
Program Report-Transplant Manitoba Adult Kidney Program Cutting Costs, Not Corners: Value of Quality Improvement Initiatives.项目报告 - 曼尼托巴省成人肾脏移植项目:削减成本,而非偷工减料:质量改进举措的价值
Can J Kidney Health Dis. 2025 Jul 1;12:20543581251341712. doi: 10.1177/20543581251341712. eCollection 2025.
2
Variation in Kidney Transplant Referral, Living Donor Contacts, Waitlisting, and Kidney Transplant Across Regional Renal Programs in Ontario, Canada: A Population-Based Cohort Study.加拿大安大略省各区域肾脏项目中肾移植转诊、活体供体联系、等待名单登记及肾移植情况的差异:一项基于人群的队列研究
Can J Kidney Health Dis. 2025 Jun 26;12:20543581251346048. doi: 10.1177/20543581251346048. eCollection 2025.
3
Defining Referral for a Kidney Transplant Evaluation as a Quality Indicator: A Population-Based Cohort Study.
将肾脏移植评估转诊定义为一项质量指标:一项基于人群的队列研究。
Can J Kidney Health Dis. 2025 Mar 21;12:20543581251317009. doi: 10.1177/20543581251317009. eCollection 2025.
4
Variation in Kidney Transplant Referral Across Chronic Kidney Disease Programs in Ontario, Canada.加拿大安大略省慢性肾病项目中肾移植转诊的差异。
Can J Kidney Health Dis. 2023 Jun 14;10:20543581231169608. doi: 10.1177/20543581231169608. eCollection 2023.
5
Using Administrative Health Care Databases to Identify Patients With End-Stage Kidney Disease With No Recorded Contraindication to Receiving a Kidney Transplant.利用行政医疗保健数据库识别无接受肾移植禁忌证记录的终末期肾病患者。
Can J Kidney Health Dis. 2022 Jul 21;9:20543581221111712. doi: 10.1177/20543581221111712. eCollection 2022.
6
An Environmental Scan and Evaluation of Quality Indicators Across Canadian Kidney Transplant Centers.加拿大肾脏移植中心的环境扫描与质量指标评估
Can J Kidney Health Dis. 2021 Jun 28;8:20543581211027969. doi: 10.1177/20543581211027969. eCollection 2021.
7
A Quality Improvement Intervention to Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD) in Patients With Chronic Kidney Disease: Clinical Research Protocol of a Cluster-Randomized Clinical Trial.一项提高慢性肾脏病患者肾移植和活体肾捐献可及性的质量改进干预措施(EnAKT LKD):一项整群随机临床试验的临床研究方案
Can J Kidney Health Dis. 2021 Apr 15;8:2054358121997266. doi: 10.1177/2054358121997266. eCollection 2021.
8
Variation in Kidney Transplant Referral: How Much More Evidence Do We Need To Justify Data Collection on Early Transplant Steps?肾移植转诊的差异:我们还需要多少证据才能证明对早期移植步骤进行数据收集是合理的?
J Am Soc Nephrol. 2019 Sep;30(9):1554-1556. doi: 10.1681/ASN.2019070674. Epub 2019 Aug 6.
9
Barriers to Education and Shared Decision Making in the Chronic Kidney Disease Population: A Narrative Review.慢性肾脏病患者教育与共同决策的障碍:一项叙述性综述
Can J Kidney Health Dis. 2018 Nov 2;5:2054358118803322. doi: 10.1177/2054358118803322. eCollection 2018.
10
Explore Transplant Ontario: Adapting the Explore Transplant Education Program to Facilitate Informed Decision Making About Kidney Transplantation.探索安大略省器官移植项目:调整探索器官移植教育计划以促进关于肾移植的明智决策。
Can J Kidney Health Dis. 2018 Jul 24;5:2054358118789369. doi: 10.1177/2054358118789369. eCollection 2018.